AUTOLOGOUS NEUTRALIZING ANTIBODIES PREVAIL IN HIV-2 BUT NOT IN HIV-1 INFECTION

被引:74
|
作者
BJORLING, E
SCARLATTI, G
VONGEGERFELT, A
ALBERT, J
BIBERFELD, G
CHIODI, F
NORRBY, E
FENYO, EM
机构
[1] KAROLINSKA INST, DEPT VIROL, S-10521 STOCKHOLM, SWEDEN
[2] NATL BACTERIOL LAB, DEPT VIROL, S-10521 STOCKHOLM, SWEDEN
[3] NATL BACTERIOL LAB, DEPT IMMUNOL, S-10521 STOCKHOLM, SWEDEN
关键词
D O I
10.1006/viro.1993.1160
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human immunodeficiency virus type 2 (HIV-2) has been reported to be less pathogenic than HIV-1. We have investigated the capacity of sera from nine HIV-2-infected individuals to neutralize their own autologous virus. All nine HIV-2-infected individuals neutralized autologous virus with titers ranging between 20 and 320. In contrast, we have previously reported that most HIV-1-infected individuals lack such antibodies. The difference between HIV-1 and HIV-2 infection was statistically significant (P < 0.0002, Pearson test) and the difference in neutralizing antibody prevalence may explain the faster disease progression in HIV-1-infected individuals than in HIV-2-infected individuals. © 1993 Academic Press, Inc.
引用
收藏
页码:528 / 530
页数:3
相关论文
共 50 条
  • [41] Comparing HIV-1 and HIV-2 infection: Lessons for viral immunopathogenesis
    Nyamweya, Samuel
    Hegedus, Andrea
    Jaye, Assan
    Rowland-Jones, Sarah
    Flanagan, Katie L.
    Macallan, Derek C.
    [J]. REVIEWS IN MEDICAL VIROLOGY, 2013, 23 (04) : 221 - 240
  • [42] Maternal HIV-1 and HIV-2 infection and child survival in The Gambia
    Ota, MOC
    O'Donovan, D
    Alabi, AS
    Milligan, P
    Yamuah, LK
    N'Gom, PT
    Harding, E
    Ariyoshi, K
    Wilkins, A
    Whittle, HC
    [J]. AIDS, 2000, 14 (04) : 435 - 439
  • [43] HIV-2 PROVIDES NATURAL PROTECTION AGAINST HIV-1 INFECTION
    KANKI, P
    TRAVERS, K
    MBOUP, S
    MARLINK, R
    AISSATOUGUEYENDIAYE
    ESSEX, M
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 : S128 - S128
  • [44] ABSENCE OF HIV-1 AND HIV-2 INFECTION IN AN AFRICAN MASSAI POPULATION
    CORRAL, JCL
    BOVEDA, MIC
    DOMINGUEZ, MJA
    BENEIT, JV
    [J]. MEDICINA CLINICA, 1992, 98 (06): : 237 - 237
  • [45] NATURAL PROTECTION AGAINST HIV-1 INFECTION PROVIDED BY HIV-2
    TRAVERS, K
    MBOUP, S
    MARLINK, R
    GUEYENDIAYE, A
    SIBY, T
    THIOR, I
    TRAORE, I
    DIENGSARR, A
    SANKALE, JL
    MULLINS, C
    NDOYE, I
    HSIEH, CC
    ESSEX, M
    KANKI, P
    [J]. SCIENCE, 1995, 268 (5217) : 1612 - 1615
  • [46] Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?
    Leonidas Stamatatos
    Lynn Morris
    Dennis R Burton
    John R Mascola
    [J]. Nature Medicine, 2009, 15 : 866 - 870
  • [47] Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?
    Stamatatos, Leonidas
    Morris, Lynn
    Burton, Dennis R.
    Mascola, John R.
    [J]. NATURE MEDICINE, 2009, 15 (08) : 866 - 870
  • [48] Seroprevalence of HIV-1, HIV-2, and HIV-1 group O in Nigeria: Evidence for a growing increase of HIV infection
    EsuWilliams, E
    MulangaKabeya, C
    Takena, H
    Zwandor, A
    Aminu, K
    Adamu, I
    Yetunde, O
    Akinsete, I
    Patrel, D
    Peeters, M
    Delaporte, E
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1997, 16 (03): : 204 - 210
  • [49] EVALUATION OF A LINE IMMUNOASSAY FOR SIMULTANEOUS CONFIRMATION OF ANTIBODIES TO HIV-1 AND HIV-2
    FRANSEN, K
    POLLET, DE
    PEETERS, M
    VANKERCKHOVEN, I
    BEELAERT, G
    VERCAUTEREN, G
    PIOT, P
    VANDERGROEN, G
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (11) : 939 - 946
  • [50] Impact of HIV-1, HIV-2, and HIV-1+2 dual infection on the outcome of tuberculosis
    Wejse, C.
    Patsche, C. B.
    Kuehle, A.
    Bamba, F. J. V.
    Mendes, M. S.
    Lemvik, G.
    Gomes, V. F.
    Rudolf, F.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2015, 32 : 128 - 134